Related Experiment Videos
Chronically streptozocin-diabetic monkey does not closely mimic human diabetic neuropathy
H Yasuda1, Y Taniguchi, Z Huitian
1Third Department of Medicine, Shiga University of Medical Science, Japan.
Experimental Neurology
|May 1, 1989
Summary
Diabetic Japanese monkeys show nerve fiber atrophy but lack key nerve damage seen in human diabetic neuropathy. These monkeys may model diabetic axonopathy but not the full spectrum of neuropathy.
Area of Science:
- Neuroscience
- Diabetology
- Primatology
Background:
- Diabetic neuropathy is a common complication of diabetes mellitus.
- Animal models are crucial for understanding diabetic neuropathy pathogenesis.
- Japanese monkeys (Macaca fuscatus) are being investigated as a potential model.
Purpose of the Study:
- To evaluate the utility of streptozocin (STZ)-induced diabetic Japanese monkeys as a model for diabetic neuropathy.
- To compare nerve fiber and microvessel morphology in diabetic and control monkeys.
Main Methods:
- Morphological examination of myelinated nerve fibers and endoneurial microvessels.
- Analysis performed at three lower limb nerve levels.
- Computer-assisted image analysis used in eight STZ-diabetic and four control monkeys (up to 36 months duration).
Main Results:
- No significant nerve fiber loss observed in diabetic monkeys.
- A trend towards nerve fiber atrophy was noted in diabetic monkeys.
- Endoneurial microvessels showed no endothelial/pericyte proliferation or basement membrane thickening.
Conclusions:
- Chronically STZ-diabetic Japanese monkeys may serve as a model for diabetic axonopathy.
- This model does not fully replicate the nerve pathology observed in human diabetic neuropathy.
- Further research is needed to refine animal models for diabetic neuropathy studies.